Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

CNRS present new data on BACE1 inhibition by JMV-2764

July 19, 2006

Zelapar for Parkinson's disease now available

July 19, 2006

BioDelivery Sciences submits Emezine study plans to FDA

July 19, 2006

Positive results for PT-502 in animal model for antidepressant activity

July 19, 2006

Memory achieves preclinical milestones in Roche collaboration

July 19, 2006

Neuroprotective effects of a component of the perineuronal net

July 19, 2006

Recent patents report novel analgesic agents

July 18, 2006

In vitro pharmacological profile of F-15063 indicates antipsychotic potential

July 18, 2006

Targeting 5-HT4 for cognitive and attention deficits in AD

July 18, 2006

Flurizan studied for Alzheimer's disease at U. of South Florida

July 18, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 7, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 7, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...